drugset / Trial / NCT06828354
A Study of SHR-A1811 in Subjects With Ovarian Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with ovarian cancer.
Timeline
- Start
- 2025-03-13
- Primary completion
- 2027-05
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxorubicin | Other / unclassified | — | — |
| Comparator | Gemcitabine | Small molecule | — | — |
| Comparator | Paclitaxel | Small molecule | — | — |
| Comparator | Topotecan | Small molecule | — | — |
| Subject | Trastuzumab Rezetecan | Monoclonal antibody | — | — |